{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:26:25Z","timestamp":1795119985616,"version":"4.10.3"},"reference-count":50,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Overexpression of high mobility group AT-hook 2 (HMGA2) is found in a number of benign and malignant tumors, including the clonal PIGA\u2212 cells in 2 cases of paroxysmal nocturnal hemoglobinuria (PNH) and some myeloproliferative neoplasms (MPNs), and recently in hematopoietic cell clones resulting from gene therapy procedures. In nearly all these cases overexpression is because of deletions or translocations that remove the 3\u2032 untranslated region (UTR) which contains binding sites for the regulatory micro RNA let-7. We were therefore interested in the effect of HMGA2 overexpression in hematopoietic tissues in transgenic mice (\u0394Hmga2 mice) carrying a 3\u2032UTR-truncated Hmga2 cDNA. \u0394Hmga2 mice expressed increased levels of HMGA2 protein in various tissues including hematopoietic cells and showed proliferative hematopoiesis with increased numbers in all lineages of peripheral blood cells, hypercellular bone marrow (BM), splenomegaly with extramedullary erythropoiesis and erythropoietin-independent erythroid colony formation. \u0394Hmga2-derived BM cells had a growth advantage over wild-type cells in competitive repopulation and serial transplantation experiments. Thus overexpression of HMGA2 leads to proliferative hematopoiesis with clonal expansion at the stem cell and progenitor levels and may account for the clonal expansion in PNH and MPNs and in gene therapy patients after vector insertion disrupts the HMGA2 locus.<\/jats:p>","DOI":"10.1182\/blood-2011-02-334425","type":"journal-article","created":{"date-parts":[[2011,4,2]],"date-time":"2011-04-02T04:46:56Z","timestamp":1301719616000},"page":"5860-5869","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":96,"title":["3\u2032UTR-truncated Hmga2 cDNA causes MPN-like hematopoiesis by conferring a clonal growth advantage at the level of HSC in mice"],"prefix":"10.1182","volume":"117","author":[{"given":"Kazuhiko","family":"Ikeda","sequence":"first","affiliation":[{"name":"Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA;"},{"name":"Division of Hematology, Washington University School of Medicine, St Louis, MO; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Mason","sequence":"additional","affiliation":[{"name":"Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA;"},{"name":"Division of Hematology, Washington University School of Medicine, St Louis, MO; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Bessler","sequence":"additional","affiliation":[{"name":"Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA;"},{"name":"Division of Hematology, University of Pennsylvania School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2019111703532107300_B1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0092-8674(93)90250-T","article-title":"Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.","volume":"73","author":"Takeda","year":"1993","journal-title":"Cell"},{"issue":"5","key":"2019111703532107300_B2","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1172\/JCI119613","article-title":"Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion.","volume":"100","author":"Rosti","year":"1997","journal-title":"J Clin Invest"},{"issue":"9","key":"2019111703532107300_B3","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1182\/blood.V87.9.3600.bloodjournal8793600","article-title":"Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria.","volume":"87","author":"Kawagoe","year":"1996","journal-title":"Blood"},{"issue":"11","key":"2019111703532107300_B4","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1038\/sj.leu.2402694","article-title":"Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones.","volume":"16","author":"Araten","year":"2002","journal-title":"Leukemia"},{"issue":"4","key":"2019111703532107300_B5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.leu.2404135","article-title":"High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome.","volume":"20","author":"Okamoto","year":"2006","journal-title":"Leukemia"},{"issue":"13","key":"2019111703532107300_B6","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1182\/blood-2006-05-025148","article-title":"Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH).","volume":"108","author":"Inoue","year":"2006","journal-title":"Blood"},{"issue":"1","key":"2019111703532107300_B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.febslet.2004.08.013","article-title":"Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer.","volume":"574","author":"Sgarra","year":"2004","journal-title":"FEBS Lett"},{"issue":"20","key":"2019111703532107300_B8","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1093\/nar\/24.20.4071","article-title":"Genomic structure and expression of the murine Hmgi-c gene.","volume":"24","author":"Zhou","year":"1996","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"2019111703532107300_B9","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1021\/bi901881c","article-title":"DNA bending by the mammalian high-mobility group protein AT hook 2.","volume":"49","author":"Chen","year":"2010","journal-title":"Biochemistry"},{"issue":"12","key":"2019111703532107300_B10","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nrc2271","article-title":"Roles of HMGA proteins in cancer.","volume":"7","author":"Fusco","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2019111703532107300_B11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1101\/gad.1554707","article-title":"Oncogenic HMGA2: short or small?","volume":"21","author":"Young","year":"2007","journal-title":"Genes Dev"},{"issue":"18","key":"2019111703532107300_B12","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/j.febslet.2007.06.072","article-title":"DNA architectural factor and proto-oncogene HMGA2 regulates key developmental genes in pluripotent human embryonic stem cells.","volume":"581","author":"Li","year":"2007","journal-title":"FEBS Lett"},{"issue":"6","key":"2019111703532107300_B13","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2007.10.054","article-title":"let-7 regulates self renewal and tumorigenicity of breast cancer cells.","volume":"131","author":"Yu","year":"2007","journal-title":"Cell"},{"issue":"2","key":"2019111703532107300_B14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cell.2008.09.017","article-title":"Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf expression.","volume":"135","author":"Nishino","year":"2008","journal-title":"Cell"},{"issue":"5818","key":"2019111703532107300_B15","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.1137999","article-title":"Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation.","volume":"315","author":"Mayr","year":"2007","journal-title":"Science"},{"issue":"9","key":"2019111703532107300_B16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1101\/gad.1540407","article-title":"The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.","volume":"21","author":"Lee","year":"2007","journal-title":"Genes Dev"},{"issue":"2","key":"2019111703532107300_B17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.leu.2403605","article-title":"Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies.","volume":"19","author":"Odero","year":"2005","journal-title":"Leukemia"},{"issue":"6543","key":"2019111703532107300_B18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/376771a0","article-title":"Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C.","volume":"376","author":"Zhou","year":"1995","journal-title":"Nature"},{"issue":"1\u20132","key":"2019111703532107300_B19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbagrm.2009.11.013","article-title":"In vivo modulation of HMGA2 expression.","volume":"1799","author":"Ashar","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"2019111703532107300_B20","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1182\/blood.V94.9.2945","article-title":"Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene.","volume":"94","author":"Tremml","year":"1999","journal-title":"Blood"},{"issue":"4","key":"2019111703532107300_B21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1242\/jcs.114.4.671","article-title":"Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice.","volume":"114","author":"Gustafsson","year":"2001","journal-title":"J Cell Sci"},{"issue":"1","key":"2019111703532107300_B22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.leu.2405043","article-title":"Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F.","volume":"22","author":"Shide","year":"2008","journal-title":"Leukemia"},{"issue":"11","key":"2019111703532107300_B23","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.189.11.1691","article-title":"bcl-x prevents apoptotic cell death of both primitive and definitive erythrocytes at the end of maturation.","volume":"189","author":"Motoyama","year":"1999","journal-title":"J Exp Med"},{"issue":"17","key":"2019111703532107300_B24","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1182\/blood-2009-04-215848","article-title":"Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease.","volume":"115","author":"Akada","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2019111703532107300_B25","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1038\/sj.leu.2404338","article-title":"Janus kinase 2 (V617F) mutation status, signal transducer and activator of transcription-3 phosphorylation and impaired neutrophil apoptosis in myelofibrosis with myeloid metaplasia.","volume":"20","author":"Mesa","year":"2006","journal-title":"Leukemia"},{"issue":"2","key":"2019111703532107300_B26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.pas.0000213338.25111.d3","article-title":"Bone marrow phospho-STAT5 expression in non-CML chronic myeloproliferative disorders correlates with JAK2 V617F mutation and provides evidence of in vivo JAK2 activation.","volume":"31","author":"Aboudola","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2019111703532107300_B27","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/leu.2008.236","article-title":"Aberrant signal transduction pathways in myeloproliferative neoplasms.","volume":"22","author":"Kota","year":"2008","journal-title":"Leukemia"},{"issue":"3","key":"2019111703532107300_B28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/mcne.2002.1181","article-title":"The calsyntenins\u2013a family of postsynaptic membrane proteins with distinct neuronal expression patterns.","volume":"21","author":"Hintsch","year":"2002","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"2019111703532107300_B29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/gcc.10297","article-title":"Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia.","volume":"39","author":"Andrieux","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"2019111703532107300_B30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1634\/stemcells.2006-0351","article-title":"Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1).","volume":"25","author":"Guglielmelli","year":"2007","journal-title":"Stem Cells"},{"issue":"7037","key":"2019111703532107300_B31","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"issue":"9464","key":"2019111703532107300_B32","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"issue":"17","key":"2019111703532107300_B33","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders.","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111703532107300_B34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"issue":"22","key":"2019111703532107300_B35","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers.","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111703532107300_B36","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/leu.2010.69","article-title":"Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1.","volume":"24","author":"Tefferi","year":"2010","journal-title":"Leukemia"},{"issue":"2","key":"2019111703532107300_B37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/0008-5472.CAN-09-3783","article-title":"Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias.","volume":"70","author":"Abdel-Wahab","year":"2010","journal-title":"Cancer Res"},{"issue":"8","key":"2019111703532107300_B38","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"issue":"5","key":"2019111703532107300_B39","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1634\/stemcells.2005-0345","article-title":"Cellular memory and hematopoietic stem cell aging.","volume":"24","author":"Kamminga","year":"2006","journal-title":"Stem Cells"},{"issue":"15","key":"2019111703532107300_B40","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1158\/0008-5472.CAN-05-0086","article-title":"High mobility group A2 potentiates genotoxic stress in part through the modulation of basal and DNA damage-dependent phosphatidylinositol 3-kinase-related protein kinase activation.","volume":"65","author":"Boo","year":"2005","journal-title":"Cancer Res"},{"issue":"13","key":"2019111703532107300_B41","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1093\/nar\/gkp375","article-title":"HMGA2 exhibits dRP\/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy.","volume":"37","author":"Summer","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"19","key":"2019111703532107300_B42","first-page":"4793","article-title":"The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis.","volume":"59","author":"Battista","year":"1999","journal-title":"Cancer Res"},{"issue":"19","key":"2019111703532107300_B43","doi-asserted-by":"crossref","first-page":"14394","DOI":"10.1074\/jbc.M000564200","article-title":"Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas.","volume":"275","author":"Arlotta","year":"2000","journal-title":"J Biol Chem"},{"issue":"20","key":"2019111703532107300_B44","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1038\/sj.onc.1205428","article-title":"Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas.","volume":"21","author":"Fedele","year":"2002","journal-title":"Oncogene"},{"issue":"15","key":"2019111703532107300_B45","doi-asserted-by":"crossref","first-page":"7453","DOI":"10.1158\/0008-5472.CAN-06-0931","article-title":"Misexpression of full-length HMGA2 induces benign mesenchymal tumors in mice.","volume":"66","author":"Zaidi","year":"2006","journal-title":"Cancer Res"},{"issue":"10","key":"2019111703532107300_B46","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1158\/0008-5472.CAN-04-0044","article-title":"The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia.","volume":"64","author":"Xu","year":"2004","journal-title":"Cancer Res"},{"issue":"24","key":"2019111703532107300_B47","doi-asserted-by":"crossref","first-page":"10121","DOI":"10.1158\/0008-5472.CAN-08-2121","article-title":"The high-mobility group A1a\/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?","volume":"68","author":"Hillion","year":"2008","journal-title":"Cancer Res"},{"issue":"7313","key":"2019111703532107300_B48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia.","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"issue":"22","key":"2019111703532107300_B49","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1182\/blood-2009-12-257352","article-title":"Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial.","volume":"115","author":"Wang","year":"2010","journal-title":"Blood"},{"issue":"20","key":"2019111703532107300_B50","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","article-title":"Stem-cell gene therapy for the Wiskott-Aldrich syndrome.","volume":"363","author":"Boztug","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/22\/5860\/1338110\/zh802211005860.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/22\/5860\/1338110\/zh802211005860.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T01:09:49Z","timestamp":1637456989000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/117\/22\/5860\/21899\/3UTRtruncated-Hmga2-cDNA-causes-MPNlike"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,2]]},"references-count":50,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2011,6,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-02-334425","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,2]]}}}